Global Bio-based Hemostatic Powder Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Bio-based Hemostatic Powder market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bio-based Hemostatic Powder include BD, Lanhine Medical, Yancheng Yankang Medical Equipment, Success Bio-Tech, Johnson & Johnson, Haiyuan Hairun, Beijing Aitekang Medical Technology, Baxter and Medtronic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bio-based Hemostatic Powder, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Bio-based Hemostatic Powder, also provides the sales of main regions and countries. Of the upcoming market potential for Bio-based Hemostatic Powder, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bio-based Hemostatic Powder sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Bio-based Hemostatic Powder market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Bio-based Hemostatic Powder sales, projected growth trends, production technology, application and end-user industry.

Bio-based Hemostatic Powder Segment by Company

BD
Lanhine Medical
Yancheng Yankang Medical Equipment
Success Bio-Tech
Johnson & Johnson
Haiyuan Hairun
Beijing Aitekang Medical Technology
Baxter
Medtronic
MedTrade Products
Hemostasis
BioCer Entwicklungs-GmbH
Bio-based Hemostatic Powder Segment by Type

Oxidized Cellulose
Polysaccharides
Other
Bio-based Hemostatic Powder Segment by Application

Surgery
First Aid
Bio-based Hemostatic Powder Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Hemostatic Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bio-based Hemostatic Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Hemostatic Powder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Bio-based Hemostatic Powder in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Bio-based Hemostatic Powder manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-based Hemostatic Powder sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Bio-based Hemostatic Powder Market by Type
1.2.1 Global Bio-based Hemostatic Powder Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oxidized Cellulose
1.2.3 Polysaccharides
1.2.4 Other
1.3 Bio-based Hemostatic Powder Market by Application
1.3.1 Global Bio-based Hemostatic Powder Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Surgery
1.3.3 First Aid
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Bio-based Hemostatic Powder Market Dynamics
2.1 Bio-based Hemostatic Powder Industry Trends
2.2 Bio-based Hemostatic Powder Industry Drivers
2.3 Bio-based Hemostatic Powder Industry Opportunities and Challenges
2.4 Bio-based Hemostatic Powder Industry Restraints
3 Global Market Growth Prospects
3.1 Global Bio-based Hemostatic Powder Revenue Estimates and Forecasts (2020-2031)
3.2 Global Bio-based Hemostatic Powder Revenue by Region
3.2.1 Global Bio-based Hemostatic Powder Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Bio-based Hemostatic Powder Revenue by Region (2020-2025)
3.2.3 Global Bio-based Hemostatic Powder Revenue by Region (2026-2031)
3.2.4 Global Bio-based Hemostatic Powder Revenue Market Share by Region (2020-2031)
3.3 Global Bio-based Hemostatic Powder Sales Estimates and Forecasts 2020-2031
3.4 Global Bio-based Hemostatic Powder Sales by Region
3.4.1 Global Bio-based Hemostatic Powder Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Bio-based Hemostatic Powder Sales by Region (2020-2025)
3.4.3 Global Bio-based Hemostatic Powder Sales by Region (2026-2031)
3.4.4 Global Bio-based Hemostatic Powder Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Bio-based Hemostatic Powder Revenue by Manufacturers
4.1.1 Global Bio-based Hemostatic Powder Revenue by Manufacturers (2020-2025)
4.1.2 Global Bio-based Hemostatic Powder Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Bio-based Hemostatic Powder Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Bio-based Hemostatic Powder Sales by Manufacturers
4.2.1 Global Bio-based Hemostatic Powder Sales by Manufacturers (2020-2025)
4.2.2 Global Bio-based Hemostatic Powder Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Bio-based Hemostatic Powder Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Bio-based Hemostatic Powder Sales Price by Manufacturers (2020-2025)
4.4 Global Bio-based Hemostatic Powder Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Bio-based Hemostatic Powder Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Bio-based Hemostatic Powder Manufacturers, Product Type & Application
4.7 Global Bio-based Hemostatic Powder Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Bio-based Hemostatic Powder Market CR5 and HHI
4.8.2 2024 Bio-based Hemostatic Powder Tier 1, Tier 2, and Tier 3
5 Bio-based Hemostatic Powder Market by Type
5.1 Global Bio-based Hemostatic Powder Revenue by Type
5.1.1 Global Bio-based Hemostatic Powder Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Bio-based Hemostatic Powder Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Bio-based Hemostatic Powder Revenue Market Share by Type (2020-2031)
5.2 Global Bio-based Hemostatic Powder Sales by Type
5.2.1 Global Bio-based Hemostatic Powder Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Bio-based Hemostatic Powder Sales by Type (2020-2031) & (Units)
5.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Type (2020-2031)
5.3 Global Bio-based Hemostatic Powder Price by Type
6 Bio-based Hemostatic Powder Market by Application
6.1 Global Bio-based Hemostatic Powder Revenue by Application
6.1.1 Global Bio-based Hemostatic Powder Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Bio-based Hemostatic Powder Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Bio-based Hemostatic Powder Revenue Market Share by Application (2020-2031)
6.2 Global Bio-based Hemostatic Powder Sales by Application
6.2.1 Global Bio-based Hemostatic Powder Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Bio-based Hemostatic Powder Sales by Application (2020-2031) & (Units)
6.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Application (2020-2031)
6.3 Global Bio-based Hemostatic Powder Price by Application
7 Company Profiles
7.1 BD
7.1.1 BD Comapny Information
7.1.2 BD Business Overview
7.1.3 BD Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BD Bio-based Hemostatic Powder Product Portfolio
7.1.5 BD Recent Developments
7.2 Lanhine Medical
7.2.1 Lanhine Medical Comapny Information
7.2.2 Lanhine Medical Business Overview
7.2.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio
7.2.5 Lanhine Medical Recent Developments
7.3 Yancheng Yankang Medical Equipment
7.3.1 Yancheng Yankang Medical Equipment Comapny Information
7.3.2 Yancheng Yankang Medical Equipment Business Overview
7.3.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio
7.3.5 Yancheng Yankang Medical Equipment Recent Developments
7.4 Success Bio-Tech
7.4.1 Success Bio-Tech Comapny Information
7.4.2 Success Bio-Tech Business Overview
7.4.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio
7.4.5 Success Bio-Tech Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Comapny Information
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio
7.5.5 Johnson & Johnson Recent Developments
7.6 Haiyuan Hairun
7.6.1 Haiyuan Hairun Comapny Information
7.6.2 Haiyuan Hairun Business Overview
7.6.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio
7.6.5 Haiyuan Hairun Recent Developments
7.7 Beijing Aitekang Medical Technology
7.7.1 Beijing Aitekang Medical Technology Comapny Information
7.7.2 Beijing Aitekang Medical Technology Business Overview
7.7.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio
7.7.5 Beijing Aitekang Medical Technology Recent Developments
7.8 Baxter
7.8.1 Baxter Comapny Information
7.8.2 Baxter Business Overview
7.8.3 Baxter Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Baxter Bio-based Hemostatic Powder Product Portfolio
7.8.5 Baxter Recent Developments
7.9 Medtronic
7.9.1 Medtronic Comapny Information
7.9.2 Medtronic Business Overview
7.9.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Medtronic Bio-based Hemostatic Powder Product Portfolio
7.9.5 Medtronic Recent Developments
7.10 MedTrade Products
7.10.1 MedTrade Products Comapny Information
7.10.2 MedTrade Products Business Overview
7.10.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio
7.10.5 MedTrade Products Recent Developments
7.11 Hemostasis
7.11.1 Hemostasis Comapny Information
7.11.2 Hemostasis Business Overview
7.11.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio
7.11.5 Hemostasis Recent Developments
7.12 BioCer Entwicklungs-GmbH
7.12.1 BioCer Entwicklungs-GmbH Comapny Information
7.12.2 BioCer Entwicklungs-GmbH Business Overview
7.12.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio
7.12.5 BioCer Entwicklungs-GmbH Recent Developments
8 North America
8.1 North America Bio-based Hemostatic Powder Market Size by Type
8.1.1 North America Bio-based Hemostatic Powder Revenue by Type (2020-2031)
8.1.2 North America Bio-based Hemostatic Powder Sales by Type (2020-2031)
8.1.3 North America Bio-based Hemostatic Powder Price by Type (2020-2031)
8.2 North America Bio-based Hemostatic Powder Market Size by Application
8.2.1 North America Bio-based Hemostatic Powder Revenue by Application (2020-2031)
8.2.2 North America Bio-based Hemostatic Powder Sales by Application (2020-2031)
8.2.3 North America Bio-based Hemostatic Powder Price by Application (2020-2031)
8.3 North America Bio-based Hemostatic Powder Market Size by Country
8.3.1 North America Bio-based Hemostatic Powder Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Bio-based Hemostatic Powder Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Bio-based Hemostatic Powder Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Bio-based Hemostatic Powder Market Size by Type
9.1.1 Europe Bio-based Hemostatic Powder Revenue by Type (2020-2031)
9.1.2 Europe Bio-based Hemostatic Powder Sales by Type (2020-2031)
9.1.3 Europe Bio-based Hemostatic Powder Price by Type (2020-2031)
9.2 Europe Bio-based Hemostatic Powder Market Size by Application
9.2.1 Europe Bio-based Hemostatic Powder Revenue by Application (2020-2031)
9.2.2 Europe Bio-based Hemostatic Powder Sales by Application (2020-2031)
9.2.3 Europe Bio-based Hemostatic Powder Price by Application (2020-2031)
9.3 Europe Bio-based Hemostatic Powder Market Size by Country
9.3.1 Europe Bio-based Hemostatic Powder Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Bio-based Hemostatic Powder Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Bio-based Hemostatic Powder Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Bio-based Hemostatic Powder Market Size by Type
10.1.1 China Bio-based Hemostatic Powder Revenue by Type (2020-2031)
10.1.2 China Bio-based Hemostatic Powder Sales by Type (2020-2031)
10.1.3 China Bio-based Hemostatic Powder Price by Type (2020-2031)
10.2 China Bio-based Hemostatic Powder Market Size by Application
10.2.1 China Bio-based Hemostatic Powder Revenue by Application (2020-2031)
10.2.2 China Bio-based Hemostatic Powder Sales by Application (2020-2031)
10.2.3 China Bio-based Hemostatic Powder Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Bio-based Hemostatic Powder Market Size by Type
11.1.1 Asia Bio-based Hemostatic Powder Revenue by Type (2020-2031)
11.1.2 Asia Bio-based Hemostatic Powder Sales by Type (2020-2031)
11.1.3 Asia Bio-based Hemostatic Powder Price by Type (2020-2031)
11.2 Asia Bio-based Hemostatic Powder Market Size by Application
11.2.1 Asia Bio-based Hemostatic Powder Revenue by Application (2020-2031)
11.2.2 Asia Bio-based Hemostatic Powder Sales by Application (2020-2031)
11.2.3 Asia Bio-based Hemostatic Powder Price by Application (2020-2031)
11.3 Asia Bio-based Hemostatic Powder Market Size by Country
11.3.1 Asia Bio-based Hemostatic Powder Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Bio-based Hemostatic Powder Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Bio-based Hemostatic Powder Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Bio-based Hemostatic Powder Market Size by Type
12.1.1 SAMEA Bio-based Hemostatic Powder Revenue by Type (2020-2031)
12.1.2 SAMEA Bio-based Hemostatic Powder Sales by Type (2020-2031)
12.1.3 SAMEA Bio-based Hemostatic Powder Price by Type (2020-2031)
12.2 SAMEA Bio-based Hemostatic Powder Market Size by Application
12.2.1 SAMEA Bio-based Hemostatic Powder Revenue by Application (2020-2031)
12.2.2 SAMEA Bio-based Hemostatic Powder Sales by Application (2020-2031)
12.2.3 SAMEA Bio-based Hemostatic Powder Price by Application (2020-2031)
12.3 SAMEA Bio-based Hemostatic Powder Market Size by Country
12.3.1 SAMEA Bio-based Hemostatic Powder Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Bio-based Hemostatic Powder Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Bio-based Hemostatic Powder Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Bio-based Hemostatic Powder Value Chain Analysis
13.1.1 Bio-based Hemostatic Powder Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Bio-based Hemostatic Powder Production Mode & Process
13.2 Bio-based Hemostatic Powder Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Bio-based Hemostatic Powder Distributors
13.2.3 Bio-based Hemostatic Powder Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings